The presence of the epidermal growth factor receptor (EGFR) gene mutation is associated with a high rate of distant metastasis and poor prognosis in patients with non-small cell lung cancer (NSCLC). EGFR signaling acts as mediator of bone metastasis by increasing tumor cell proliferation and promotes synthesis and secretion of numerous angiogenic growth factors. We propose that metastatic bone lesions with and without the EGFR mutation in primary NSCLC have different perfusion profiles and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters can reveal the differences.
This abstract and the presentation materials are available to members only; a login is required.